• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antipsoriatic treatments during COVID-19 outbreak.

作者信息

Di Lernia Vito

机构信息

Dermatology Unit, Department of Medical Specialties, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.

DOI:10.1111/dth.13345
PMID:32223073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228205/
Abstract
摘要

相似文献

1
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
2
Comment on "Antipsoriatic treatments during COVID-19 outbreak".关于“新冠肺炎疫情期间的银屑病治疗”的评论
Dermatol Ther. 2020 Jul;33(4):e13491. doi: 10.1111/dth.13491. Epub 2020 Jun 12.
3
Biologic therapy for psoriasis during the COVID-19 outbreak: The choice is to weigh risks and benefits.2019冠状病毒病疫情期间银屑病的生物治疗：选择需权衡风险与获益。
Dermatol Ther. 2020 Jul;33(4):e13490. doi: 10.1111/dth.13490. Epub 2020 May 20.
4
Biologics for psoriasis in COVID-19 era: What do we know?新冠疫情时代用于治疗银屑病的生物制剂：我们了解什么？
Dermatol Ther. 2020 Jul;33(4):e13467. doi: 10.1111/dth.13467. Epub 2020 Jun 15.
5
Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".关于《COVID-19与银屑病：是时候限制免疫抑制剂治疗了吗？行动呼吁》的评论
Dermatol Ther. 2020 Jul;33(4):e13360. doi: 10.1111/dth.13360. Epub 2020 Apr 16.
6
Psoriasis and psoriatic arthritis: How to manage immunosuppressants in COVID-19 days.银屑病和银屑病关节炎：在新冠疫情期间如何管理免疫抑制剂
Dermatol Ther. 2020 Jul;33(4):e13415. doi: 10.1111/dth.13415. Epub 2020 May 2.
7
COVID-19 in an elderly patient treated with secukinumab.一位接受司库奇尤单抗治疗的老年患者的新型冠状病毒肺炎
Dermatol Ther. 2020 Jul;33(4):e13580. doi: 10.1111/dth.13580. Epub 2020 May 27.
8
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
9
Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.在新冠疫情期间，银屑病的生物治疗并非一种选择。
J Dermatolog Treat. 2020 Jun;31(4):320-321. doi: 10.1080/09546634.2020.1749545. Epub 2020 Apr 6.
10
Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.银屑病患者的机会性病毒感染：在新冠疫情时代阿普米拉斯更安全的选择。
Dermatol Ther. 2020 Jul;33(4):e13618. doi: 10.1111/dth.13618. Epub 2020 Jun 4.

引用本文的文献

1
The Relationship Between Psoriasis, COVID-19 Infection and Vaccination During Treatment of Patients.银屑病、COVID-19 感染与治疗期间疫苗接种的关系。
Adv Exp Med Biol. 2023;1412:339-355. doi: 10.1007/978-3-031-28012-2_18.
2
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities.2019年冠状病毒病大流行期间中重度银屑病的治疗：经验教训与机遇
J Clin Med. 2022 Apr 26;11(9):2422. doi: 10.3390/jcm11092422.
3
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?2019年冠状病毒病大流行对慢性炎症性免疫介导性皮肤病病程及管理的影响：有哪些证据？
Clin Dermatol. 2021 Jan-Feb;39(1):52-55. doi: 10.1016/j.clindermatol.2020.12.012. Epub 2020 Dec 15.
4
Biologics for Psoriasis during the COVID-19 Pandemic.新冠疫情期间用于治疗银屑病的生物制剂
J Clin Med. 2021 Mar 30;10(7):1390. doi: 10.3390/jcm10071390.
5
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review.潜在的针对病毒生命周期进入后阶段的抗 SARS-CoV-2 治疗药物：全面综述。
Viruses. 2020 Sep 26;12(10):1092. doi: 10.3390/v12101092.
6
Harnessing Memory NK Cell to Protect Against COVID-19.利用记忆性自然杀伤细胞预防新冠病毒
Front Pharmacol. 2020 Aug 20;11:1309. doi: 10.3389/fphar.2020.01309. eCollection 2020.
7
Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review.COVID-19 大流行中的皮肤表现和注意事项：系统评价。
Dermatol Ther. 2020 Nov;33(6):e13986. doi: 10.1111/dth.13986. Epub 2020 Aug 6.
8
Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".关于《银屑病、COVID-19与急性呼吸窘迫综合征：关注生物治疗联合应用的风险》的评论
Dermatol Ther. 2020 Nov;33(6):e13840. doi: 10.1111/dth.13840. Epub 2020 Jul 6.
9
Covid-19 infection in psoriasis patients treated with cyclosporin.接受环孢素治疗的银屑病患者感染新冠病毒19
Dermatol Ther. 2020 Jul;33(4):e13739. doi: 10.1111/dth.13739. Epub 2020 Jun 24.
10
Moderate-to-severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak.2019年冠状病毒病疫情期间接受全身治疗的中重度化脓性汗腺炎
Dermatol Ther. 2020 Jul;33(4):e13680. doi: 10.1111/dth.13680. Epub 2020 Jun 18.

本文引用的文献

1
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
2
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
4
The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.抑制PP1和TNFα信号传导对严重急性呼吸综合征冠状病毒发病机制的影响。
BMC Syst Biol. 2016 Sep 23;10(1):93. doi: 10.1186/s12918-016-0336-6.
5
Coronaviruses - drug discovery and therapeutic options.冠状病毒——药物研发与治疗选择
Nat Rev Drug Discov. 2016 May;15(5):327-47. doi: 10.1038/nrd.2015.37. Epub 2016 Feb 12.
6
Suppression of coronavirus replication by cyclophilin inhibitors.环孢素抑制剂抑制冠状病毒复制。
Viruses. 2013 May 22;5(5):1250-60. doi: 10.3390/v5051250.
7
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.严重急性呼吸综合征冠状病毒-宿主相互作用组：亲环素作为泛冠状病毒抑制剂的靶标鉴定。
PLoS Pathog. 2011 Oct;7(10):e1002331. doi: 10.1371/journal.ppat.1002331. Epub 2011 Oct 27.
8
Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.非细胞毒性浓度的化疗药物通过白细胞介素-12依赖机制增加树突状细胞的抗原呈递。
J Immunol. 2009 Jul 1;183(1):137-44. doi: 10.4049/jimmunol.0900734. Epub 2009 Jun 17.
9
Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway.严重急性呼吸综合征冠状病毒刺突蛋白通过核因子κB途径诱导小鼠巨噬细胞中白细胞介素-6和肿瘤坏死因子-α的上调。
Virus Res. 2007 Sep;128(1-2):1-8. doi: 10.1016/j.virusres.2007.02.007. Epub 2007 May 25.